RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EPIX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ESSA Pharma Inc. stock price ended at $4.78 on Wednesday, after losing 3.04%.
(Updated on Jul 03, 2024)

Sell candidate since Jul 01, 2024 Loss -6.64% PDF

The ESSA Pharma Inc. stock price fell by -3.04% on the last day (Wednesday, 3rd Jul 2024) from $4.93 to $4.78. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.24% from a day low at $4.75 to a day high of $5.00. The price has fallen in 5 of the last 10 days but is still up by 2.58% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -18 thousand shares and in total, 12 thousand shares were bought and sold for approximately $58.27 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.57% during the next 3 months and, with a 90% probability hold a price between $2.67 and $3.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EPIX Signals & Forecast

There are mixed signals in the stock today. The ESSA Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.02 and $5.60. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Thursday, June 13, 2024, and so far it has risen 3.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ESSA Pharma Inc. stock

ESSA Pharma Inc. finds support from accumulated volume at $4.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.249 between high and low, or 5.24%. For the last week the stock has had daily average volatility of 7.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EPIX) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect ESSA Pharma Inc. to open at $4.84, and during the day (based on 14 day Average True Range), to move between $4.33 and $5.23, which gives a possible trading interval of +/-$0.451 (+/-9.44%) up or down from last closing price. If ESSA Pharma Inc. takes out the full calculated possible swing range there will be an estimated 18.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.90 (2.51%) than the support at $4.66 (2.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ESSA Pharma Inc. stock A Buy?

ESSA Pharma Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.833 Sell Candidate Unchanged

Predicted Opening Price for ESSA Pharma Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$4.84 ( 1.32%) $4.78

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EPIX

Fibonacci Support & Resistance Levels

Level Price
R3 5.09 6.53%
R2 5.00 4.54%
R1 4.94 3.31%
Price 4.78
S1 4.75 -0.672%
S2 4.69 -1.90%
S3 4.59 -3.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.43 13.60%
R2 4.98 4.18%
R1 4.90 2.51%
Price 4.78
S1 4.66 -2.51%
S2 4.63 -3.14%
S3 0 -

FAQ

What is the symbol for ESSA Pharma Inc. Stock and on which exchange is it traded?
The symbol for ESSA Pharma Inc. is EPIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ESSA Pharma Inc. Stock?
ESSA Pharma Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy ESSA Pharma Inc. Stock?
ESSA Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ESSA Pharma Inc. Stock.

What's the current price of ESSA Pharma Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an ESSA Pharma Inc. (EPIX) share was $4.78.

What is the 52-week high and low for ESSA Pharma Inc. Stock?
The 52-week high for ESSA Pharma Inc. Stock is $11.67 and the 52-week low is $2.58.

What is the market capitalization of ESSA Pharma Inc. Stock?
As of the Jul 03, 2024, the market capitalization of ESSA Pharma Inc. is 212.055M.

When is the next earnings date for ESSA Pharma Inc.?
The upcoming earnings date for ESSA Pharma Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT